[ET Net News Agency, 19 August 2020] DBS Group Research re-initiated coverage on Hengan
International (01044) with a "buy" rating and a target price of HK$76.51 for its recovery
of sanitary napkin business (key profit contributor) post-reform.
For a good bet across the overall tissue and personal care market, the research house
likes Hengan. Its tissue, sanitary napkin, and diaper segment made up 51.1%, 28.8%, and
6.4% of total revenue in 2019.
DBS believes Hengan is on track to see sales recovery in 2Q, thanks to ongoing product
mix upgrade and channel restocking. It expects to see earnings to grow by a mid-teen rate
in FY2020. (KL)
|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01044 HENGAN INT'L
Nominal 
23.800 +1.250 (+5.543%) Research Report
19/08/2020 11:32
{I-bank focus}DBS restarts Hengan Int'l (01044) at HK$76.51
| Remark: | Real time quote last updated: 24/09/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service |